Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients
- 31 March 1999
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 35 (3) , 398-405
- https://doi.org/10.1016/s0959-8049(98)00400-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastasesBreast Cancer Research and Treatment, 1998
- Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapyNature Medicine, 1995
- TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosisEuropean Journal Of Cancer, 1995
- TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domainsGenes, Chromosomes and Cancer, 1995
- p53 and human cancersBritish Medical Bulletin, 1994
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Prognostic significance of TP53 alterations in breast carcinomaBritish Journal of Cancer, 1993
- p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic GradeJapanese Journal of Cancer Research, 1993
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- p53 Mutations in Human CancersScience, 1991